Coagulation Response and Prothrombotic Effect of Uninterrupted Oral Anticoagulant Administration After Catheter Ablation for VT

JACC: Clinical Electrophysiology - Tập 8 - Trang 735-748 - 2022
Satoshi Yanagisawa1,2, Yasuya Inden2, Shuro Riku2, Koichi Furui2, Kazumasa Suga2, Toshifumi Nakagomi2, Masafumi Shimojo2, Takashi Okajima2, Ryo Watanabe2, Naoki Tsurumi2, Noriyuki Suzuki2, Rei Shibata1, Toyoaki Murohara2
1Department of Advanced Cardiovascular Therapeutics, Nagoya University Graduate School of Medicine, Nagoya, Japan
2Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan

Tài liệu tham khảo

Bohnen, 2011, Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias, Heart Rhythm, 8, 1661, 10.1016/j.hrthm.2011.05.017 Peichl, 2014, Complications of catheter ablation of ventricular tachycardia: a single-center experience, Circ Arrhythm Electrophysiol, 7, 684, 10.1161/CIRCEP.114.001530 Tung, 2015, Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group study, Heart Rhythm, 12, 1997, 10.1016/j.hrthm.2015.05.036 Siontis, 2018, Thromboembolic prophylaxis protocol with warfarin after radiofrequency catheter ablation of infarct-related ventricular tachycardia, J Cardiovasc Electrophysiol, 29, 584, 10.1111/jce.13418 Yousuf, 2018, Trends and outcomes of catheter ablation for ventricular tachycardia in a community cohort, J Am Coll Cardiol EP, 4, 1189 Whitman, 2017, Brain emboli after left ventricular endocardial ablation, Circulation, 135, 867, 10.1161/CIRCULATIONAHA.116.025546 Cronin, 2020, 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias, Heart Rhythm, 17, e2, 10.1016/j.hrthm.2019.03.002 Calkins, 2017, 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation, Heart Rhythm, 14, e275, 10.1016/j.hrthm.2017.05.012 Nogami, 2021, JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias, J Arrhythm, 37, 709 Yanagisawa, 2019, Prothrombotic responses after catheter ablation for atrial fibrillation during uninterrupted oral anticoagulant agent administration, J Am Coll Cardiol EP, 5, 1418 2014, Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013), Circ J, 78, 1997, 10.1253/circj.CJ-66-0092 Konishi, 2022, Comparison of microemboli formation between irrigated catheter tip architecture using a microemboli monitoring system, J Am Coll Cardiol EP, 8, 26 Tang, 2016, Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis, Lancet Haematol, 3, e30, 10.1016/S2352-3026(15)00228-8 Lakkireddy, 2021, Safety/efficacy of DOAC versus aspirin for reduction of risk of cerebrovascular events following VT ablation, J Am Coll Cardiol EP, 7, 1493 Heeger, 2018, Cerebral protection during catheter ablation of ventricular tachycardia in patients with ischemic heart disease, J Am Heart Assoc, 7 Nagao, 2019, Impact of periprocedural anticoagulation therapy on the incidence of silent stroke after atrial fibrillation ablation in patients receiving direct oral anticoagulants: uninterrupted vs. interrupted by one dose strategy, Europace, 21, 590, 10.1093/europace/euy224 Schwarz, 2010, Neuropsychological decline after catheter ablation of atrial fibrillation, Heart Rhythm, 7, 1761, 10.1016/j.hrthm.2010.07.035 Sawhney, 2016, Epicardial catheter ablation for ventricular tachycardia on uninterrupted warfarin: a safe approach for those with a strong indication for peri-procedural anticoagulation?, Int J Cardiol, 222, 57, 10.1016/j.ijcard.2016.07.113 Kimura, 2018, Asymptomatic cerebral infarction during catheter ablation for atrial fibrillation: comparing uninterrupted rivaroxaban and warfarin (ASCERTAIN), J Am Coll Cardiol EP, 4, 1598 Di Biase, 2015, Ablation of stable VTs versus substrate ablation in ischemic cardiomyopathy: the VISTA randomized multicenter trial, J Am Coll Cardiol, 66, 2872, 10.1016/j.jacc.2015.10.026 Gökoğlan, 2016, Scar homogenization versus limited-substrate ablation in patients with nonischemic cardiomyopathy and ventricular tachycardia, J Am Coll Cardiol, 68, 1990, 10.1016/j.jacc.2016.08.033